Harrow Times on MSN

Harrow: World-class theatre and opera shows on big screen

Vue Harrow cinema will screen top British theatre and opera in early 2026, including Royal Opera’s La Traviata, NT’s Hamlet, and The ...

Harrow, Inc. (HROW): A bull case theory

We came across a bullish thesis on Harrow, Inc. on MVC Investing’s Substack by M. V. Cunha. In this article, we will ...

Harrow: Flirting With Missing 2025 Revised Guidance

Harrow is a fast-growing ophthalmic pharma company focused on delivering eye care drugs. Click here to read more about HROW's ...
Seeking Alpha

Harrow: When Cheaper Doesn't Mean Attractive (Rating Upgrade)

Harrow's stock is down 17% since my last analysis and "Sell" recommendation. Harrow's Q4 and FY24 results show significant revenue growth and improved net income, but the company faces complex ...
Vox

In the dazzling Harrow the Ninth, the lesbian necromancers are back in space

Constance Grady is a senior correspondent on the Culture team for Vox, where since 2016 she has covered books, publishing, gender, celebrity analysis, and theater. I couldn’t tell that there was ...
MM&M

Novartis sells U.S. rights to five drugs to Harrow for up to $175M

Harrow Health, an eye care pharmaceutical company, announced Wednesday morning that Novartis agreed to sell five drugs approved by the Food and Drug Administration for up to $175 million. Harrow will ...